Ludvik, B., et al., Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial
R., et al., LongActing Peptidomimetics Based DPPIV Inhibitors, Bioorganic & Medicinal Chemistry Letters 22, no
The drugs have exploded in popularity, leading to today's global shortage
Seek medical attention immediately, infections require antibiotic treatment
Liraglutide exhibits potential anti-tumor effects on the progression of intrahepatic cholangiocarcinoma, in vitro and in vivo
99% HPLC purity, COA every batch, same-day dispatch